Legend Biotech Corp. (LEGN)
18.63
-0.56
(-2.92%)
USD |
NASDAQ |
Sep 11, 16:00
18.80
+0.17
(+0.91%)
After-Hours: 17:29
Legend Biotech Gross Profit (TTM) : 675.55M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 675.55M |
| March 31, 2026 | 588.50M |
| December 31, 2025 | 593.08M |
| September 30, 2025 | 526.80M |
| June 30, 2025 | 474.95M |
| March 31, 2025 | 453.90M |
| December 31, 2024 | 368.92M |
| September 30, 2024 | 305.16M |
| June 30, 2024 | 253.26M |
| March 31, 2024 | 163.21M |
| December 31, 2023 | 130.41M |
| September 30, 2023 | 88.16M |
| June 30, 2023 | 42.70M |
| March 31, 2023 | -2.924M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.647M |
| September 30, 2022 | -3.067M |
| June 30, 2022 | -4.968M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Dianthus Therapeutics, Inc. | 1.525M |
| Gilead Sciences, Inc. | 24.33B |
| Ironwood Pharmaceuticals, Inc. | 387.48M |
| Arbutus Biopharma Corp. | 181.68M |
| Fortress Biotech, Inc. | 40.31M |